Jade Biosciences News and Activities

Presence

Jade Biosciences is a biotechnology company that develops antibody medicines for immune and inflammatory diseases. Its services include drug discovery and clinical development for patients, healthcare providers, and research partners.

Jade Biosciences products and services overview:

Antibody therapeutics
Drug discovery
Clinical development
Autoimmune treatments
Inflammation therapies

Revenue: ~$0 million

Employees: 25

Headquarters: Boston, United States (USA)

Jade Biosciences is one of the...

Jade Biosciences is a company listed under the stock ticker JBIO (US).

Acquisition, funding and merger involving Jade Biosciences.

Jade Biosciences and Aerovate Therapeutics have announced they will merge (posted on April 30 2025)..
Jade Biosciences has just announced a $95 Million fundraising (posted on November 7 2024).

Executives

View the org chart displaying its 25 main executives

Most searched biographies at Jade Biosciences

Popular executive movements at Jade Biosciences

Edward Conner has joined the company as Chief Medical Officer (posted on April 22 2026).
Hetal Kocinsky, Chief Medical Officer, has left the company (posted on September 10 2025).

Create your alert
to follow the executive moves at Jade Biosciences.